Education
About Us
Working with TipRanks
Follow Us
LABORATORIO REIG JOFRE (GB:0RB1)
:0RB1
0RB1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€2.50 - €3.38
Previous CloseN/A
Volume1.25K
Average Volume (3M)362.00
Market Cap
€255.51M
Enterprise ValueN/A
Total Cash (Recent Filing)€10.60M
Total Debt (Recent Filing)€65.36M
Price to Earnings (P/E)23.7
Beta0.28
Next Earnings
Jul 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 15, 2025Dividend Yield1.24%
Share Statistics
EPS (TTM)0.04
Shares Outstanding80,895,750
10 Day Avg. Volume595
30 Day Avg. Volume362
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LABORATORIO REIG JOFRE News
PremiumCompany Announcements
Reig Jofre Announces Free Capital Increase and Flexible Dividend Options
PremiumCompany Announcements
Reig Jofre Announces Board Secretary Change
PremiumCompany Announcements
Reig Jofre Announces Flexible Dividend Options Through Capital Increase
PremiumCompany Announcements
REIG JOFRE’s Q1 2025 Results: Operational Gains and International Expansion
PremiumCompany Announcements
REIG JOFRE Secures 13 Million Euro Grant for Pharmaceutical InnovationPremiumCompany Announcements
Laboratorio Reig Jofre Outlines Director Remuneration Policy for 2023-2025PremiumCompany Announcements
Reig Jofre Achieves Record Profit and Expands Globally in 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
0RB1 FAQ
What was LABORATORIO REIG JOFRE’s price range in the past 12 months?
LABORATORIO REIG JOFRE lowest share price was €2.50 and its highest was €3.38 in the past 12 months.
What is LABORATORIO REIG JOFRE’s market cap?
LABORATORIO REIG JOFRE’s market cap is €255.51M.
When is LABORATORIO REIG JOFRE’s upcoming earnings report date?
LABORATORIO REIG JOFRE’s upcoming earnings report date is Jul 25, 2025 which is in 49 days.
How were LABORATORIO REIG JOFRE’s earnings last quarter?
LABORATORIO REIG JOFRE released its earnings results on May 09, 2025. The company reported €0.045 earnings per share for the quarter, beating the consensus estimate of N/A by €0.045.
Is LABORATORIO REIG JOFRE overvalued?
According to Wall Street analysts LABORATORIO REIG JOFRE’s price is currently Overvalued.
Does LABORATORIO REIG JOFRE pay dividends?
LABORATORIO REIG JOFRE pays a Annually dividend of €0.039 which represents an annual dividend yield of 1.24%. See more information on LABORATORIO REIG JOFRE dividends here
What is LABORATORIO REIG JOFRE’s EPS estimate?
LABORATORIO REIG JOFRE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LABORATORIO REIG JOFRE have?
LABORATORIO REIG JOFRE has 80,895,750 shares outstanding.
What happened to LABORATORIO REIG JOFRE’s price movement after its last earnings report?
LABORATORIO REIG JOFRE reported an EPS of €0.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.338%.
Which hedge fund is a major shareholder of LABORATORIO REIG JOFRE?
Currently, no hedge funds are holding shares in GB:0RB1
Company Description
LABORATORIO REIG JOFRE
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.
Technical Analysis
Almirall
―
Faes Farma
―
Laboratorios Farmaceuticos Rovi
―
Oryzon Genomics SA
―
Atrys Health SA
―